For the quarter ending 2025-12-31, ENTA has $329,503K in assets. $202,912K in debts. $37,437K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Income tax receivable | - | 0 | 24 | |
| Cash and cash equivalents | 37,437 | 32,298 | 44,812 | |
| Short-term marketable securities | 148,412 | 156,566 | 159,299 | |
| Short-term restricted cash | - | 0 | 0 | |
| Accounts receivable | 8,493 | 6,882 | 8,333 | |
| Prepaid expenses and other current assets | 4,342 | 8,590 | 10,240 | |
| Total current assets | 198,684 | 204,336 | 222,708 | |
| Property and equipment | - | 59,200 | - | |
| Less accumulated depreciation and amortization | - | 23,805 | - | |
| Long-term marketable securities | 56,055 | - | - | |
| Property and equipment, net | 34,308 | 35,395 | 36,617 | |
| Operating lease, right-of-use assets | 37,003 | 37,549 | 38,250 | |
| Long-term restricted cash | 3,360 | 3,360 | 3,360 | |
| Other long-term assets | 93 | 92 | 94 | |
| Total assets | 329,503 | 280,732 | 301,029 | |
| Accounts payable | 1,885 | 1,948 | 3,547 | |
| Accrued expenses and other current liabilities | 7,575 | 12,751 | 10,853 | |
| Liability related to the sale of future royalties | 31,981 | 30,710 | 27,755 | |
| Operating lease liabilities | 3,287 | 3,146 | 2,394 | |
| Total current liabilities | 44,728 | 48,555 | 44,549 | |
| Liability related to the sale of future royalties, net of current portion | 102,822 | 111,132 | 119,943 | |
| Operating lease liabilities, net of current portion | 53,782 | 54,757 | 55,656 | |
| Series 1 nonconvertible preferred stock | 1,311 | 1,311 | 1,350 | |
| Other long-term liabilities | 269 | 260 | 252 | |
| Total liabilities | 202,912 | 216,015 | 221,750 | |
| Common stock 0.01 par value per share, 100,000 shares authorized 29,019 and 21,387 shares issued and outstanding at december 31, 2025 and september 30, 2025, respectively | 290 | 214 | 214 | |
| Additional paid-in capital | 543,497 | 469,771 | 465,696 | |
| Accumulated other comprehensive loss | -329 | -339 | -402 | |
| Accumulated deficit | -416,867 | -404,929 | -386,229 | |
| Total stockholders' equity | 126,591 | 64,717 | 79,279 | |
| Total liabilities and stockholders' equity | 329,503 | 280,732 | 301,029 | |
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)